Daniele Ramazzotti

18PUBLICATIONS
83CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models.

|Jul 10, 2025
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors.

Matteo Villa, Federica Malighetti, Luca De Sano

|Mar 13, 2025
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis.

Federica Malighetti, Matteo Villa, Alberto Maria Villa

|Jan 08, 2025
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies.

Federica Malighetti, Matteo Villa, Mario Mauri

|Oct 31, 2024
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.

Matteo Villa, Geeta G Sharma, Federica Malighetti

|Jul 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.

Javier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn

Pageof 3

Frequent Collaborators

6 joint publications

Luca Mologni

5 joint publications

Federica Malighetti

5 joint publications

Rocco Piazza

5 joint publications

Matteo Villa